Teclistamab in Relapsed Refractory Multiple Myeloma: Multi-Institutional Real-World Study

被引：3

作者：

Mohan, Meera ^{[1
]}

Shah, Nishi ^{[2
]}

Luan, Danny ^{[3
]}

Monge, Jorge ^{[4
]}

Forsberg, Mark ^{[5
,6
]}

Bhatlapenumarthi, Vineel ^{[7
]}

Balev, Metodi ^{[8
]}

Patwari, Anannya ^{[9
]}

Cheruvalath, Heloise ^{[10
]}

Bhutani, Divaya ^{[11
]}

Thanendrarajan, Sharmilan ^{[12
]}

Dhakal, Binod ^{[13
]}

Zangari, Maurizio ^{[12
]}

Al Hadidi, Samer ^{[12
]}

Cooper, Dennis L. ^{[14
]}

Lentzsch, Suzanne ^{[15
]}

van Rhee, Frits ^{[12
]}

D'Souza, Anita ^{[16
]}

Szabo, Aniko ^{[9
]}

Schinke, Carolina ^{[17
]}

Chakraborty, Rajshekhar ^{[8
]}

机构：

[1] Med Coll Wisconsin, Dept Med, BMT & Cellular Therapy Program, Milwaukee, WI USA

[2] Montefiore Med Ctr, Oncol, Albert Einstein Coll Med, Bronx, NY USA

[3] Newyork Presbyterian Hosp, Weill Cornell Med Coll, New York, NY USA

[4] Weill Cornell Med, New York, NY USA

[5] Montefiore Med Ctr, Dept Oncol, Bronx, NY USA

[6] Albert Einstein Coll Med, Bronx, NY USA

[7] Med Coll Wisconsin, Dept Hematol Oncol, Milwaukee, WI USA

[8] Columbia Univ, Irving Med Ctr, New York, NY USA

[9] Med Coll Wisconsin, Milwaukee, WI USA

[10] Med Coll Wisconsin, Sch Med, Milwaukee, WI USA

[11] Columbia Univ, Coll Phys & Surg, New York, NY USA

[12] Univ Arkansas Med Sci, Winthrop P Rockefeller Canc Inst, Myeloma Ctr, Little Rock, AR USA

[13] Med Coll Wisconsin, Wauwatosa, WI USA

[14] Montefiore Med Ctr, New York, NY USA

[15] Columbia Univ, Irving Med Ctr, New York Presbyterian, New York, NY USA

[16] Med Coll Wisconsin Inc, Milwaukee, WI USA

[17] Myeloma Inst, Little Rock, AR USA

来源：

BLOOD | 2023年 / 142卷

关键词：

D O I：

10.1182/blood-2023-174875

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：5

共 50 条

[21] Real-World Outcomes with Panobinostat in Patients with Relapsed/Refractory Multiple Myeloma
Biran, Noa
Vesole, David H.
Zhang, Shijia
Richter, Joshua R.
Kuo, Yen-Hong
Schmidt, Linda
McBride, Laura
Anand, Palka
Ivanovski, Kristin
Pierre, Amy
Kumka, Susan
Cuccurullo, Carmela
Siegel, David S.
BLOOD, 2016, 128 (22)
[22] Real-World Clinical Outcomes of Teclistamab and Talquetamab in Relapsed/Refractory Multiple Myeloma (RRMM): A UK Single-Centre Experience
Feixas, Pablo Tenorio
Cox, Catrin
Peer, Xavier
Cuthill, Kirsty
Benjamin, Reuben
Gunawan, Arief
Cuadrado, Maria
de Farias, Madson Correia
Jones, John
Shin, Jin-Sup
Batool, Asma
Bowcock, Stella
Omer, Musab
Tawde, Prachi
Bailey, Katharine
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S92 - S92
[23] Belantamab mafodotin for relapsed/refractory multiple myeloma: a real-world observational study update
Hultcrantz, Malin
Kleinman, David
Vij, Ravi
Escalante, Fernando
Delforge, Michel
Kotowsky, Nirali
Bitetti, Jacopo
Boytsov, Natalie
Camadoo-O'Byrne, Leena
Happ, Lindsey Powers
Rohman, Mujib
Germain, Guillaume
Duh, Mei Sheng
Laliberte, Francois
Mahendran, Malena
Urosevic, Ana
Lee, Hans
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S185 - S186
[24] Real-world safety and efficacy of teclistamab in relapsed/refractory multiple myeloma: results from a multicenter, retrospective study and descriptive meta-analysis
Varma, Gaurav
Fogel, Lindsay
Gordon, Beth
Saldarriaga, Mateo Mejia
Ahn, Jaeil
Aleman, Adolfo
Caro, Jessica
Rosenberg, Maya C.
Monge, Jorge
Parmar, Harsh
Kaminetzky, David
Moskovits, Tibor
Siegel, David S.
Morgan, Gareth J.
Niesvizky, Ruben
Davies, Faith E.
Biran, Noa
LEUKEMIA & LYMPHOMA, 2025,
[25] Belantamab Mafodotin for Relapsed or Refractory Multiple Myeloma: A Real-World Observational Study Update
Hultcrantz, Malin
Kleinman, David
Vij, Ravi
Escalante, Fernando
Delforge, Michel
Kotowsky, Nirali
Bitetti, Jacopo
Boytsov, Natalie
Camadoo-O'Byrne, Leena
Happ, Lindsey Powers
Rohman, Mujib
Germain, Guillaume
Duh, Mei Sheng
Laliberte, Francois
Mahendran, Malena
Urosevic, Ana
Lee, Hans
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S504 - S504
[26] Talquetamab plus Teclistamab in Relapsed or Refractory Multiple Myeloma
Cohen, Yael C.
Magen, Hila
Gatt, Moshe
Sebag, Michael
Kim, Kihyun
Min, Chang-Ki
Ocio, Enrique M.
Yoon, Sung-Soo
Chu, Michael P.
Rodriguez-Otero, Paula
Avivi, Irit
Quijano Carde, Natalia A.
Kumar, Ashwini
Krevvata, Maria
Peterson, Michelle R.
Di Scala, Lilla
Scott, Emma
Hilder, Brandi
Vanak, Jill
Banerjee, Arnob
Oriol, Albert
Morillo, Daniel
Mateos, Maria-Victoria
NEW ENGLAND JOURNAL OF MEDICINE, 2025, 392 (02): : 138 - 149
[27] Teclistamab for relapsed refractory multiple myeloma patients on dialysis
Lebreton, P.
Lachenal, F.
Bouillie, S.
Pica, G. M.
Aftisse, H.
Pascal, L.
Montes, L.
Macro, M.
Johnson, N.
Harel, S.
Fernandez, M.
De Renzis, B.
Lioure, B.
Lazareth, A.
Javelot, M.
Louni, C.
Huart, A.
Perrot, A.
BRITISH JOURNAL OF HAEMATOLOGY, 2024, 205 (05) : 2077 - 2079
[28] Real-world outcomes of teclistamab for the treatment of relapsed/refractory multiple myeloma at UC San Diego Health: A single-institution experience
Ghamsari, Farid
Trando, Aaron
Medley, Katherine
Martino, Janine
Block, Shanna
Wells, Kaitlyn
Doan, Thu
Quach, Anthony
Cheng, Renee
Costello, Caitlin
Jeong, Autumn
Saunders, Ila
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S55 - S55
[29] Real-world outcomes of teclistamab for the treatment of relapsed/refractory multiple myeloma at UC San Diego Health: A single-institution experience
Ghamsari, Farid
Trando, Aaron
Medley, Katherine
Martino, Janine
Block, Shanna
Doan, Thu
Wells, Kaitlyn
Quach, Anthony C.
Cheng, Renee Gong
Costello, Caitlin
Jeong, Ah-Reum
Saunders, Ila M.
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
[30] BCMA x CD3 bispecific antibody treatment with teclistamab in relapsed and/or refractory multiple myeloma: a real-world monocentric analysis
Schaefers, C.
Thiele, B.
Alsdorf, W.
Kosch, R.
Leypoldt, L.
Bokemeyer, C.
Weisel, K.
Kamili, A.
ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 312 - 312

← 1 2 3 4 5 →